ORAL FORMULATIONS OF EDARAVONE AND METHOD OF MANUFACTURING THEREOF

The present invention relates to oral suspension dosage form of Edaravone. The invention also relates to provide patient-compliant, economical and technically advanced dosage form over existing marketed dosage form. Moreover, the solubility and stability of the patient compliant Edaravone formulatio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PATIL MAYURKUMAR PURSHOTTAMBHAI, TRIVEDI MADHAVKUMAR DILIPBHAI, JADAV NIRAV NATVARLAL, CHOKSI RAKSHIT KETANBHAI, PATEL BHAVESH NAGINBHAI, SHAH JIGAR ATULKUMAR, SHAH DHARMESH MAHENDRABHAI, THAKKAR VISHAL JAYANTILAL, BADIGER ARAVIND MANAPPA, VORA PRATIK ASHWINBHAI
Format:	Patent
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to oral suspension dosage form of Edaravone. The invention also relates to provide patient-compliant, economical and technically advanced dosage form over existing marketed dosage form. Moreover, the solubility and stability of the patient compliant Edaravone formulation, prepared as per the present invention, is proven higher when compared to prior art inventions. Furthermore, the present invention also provides a suspension composition prepared by a process which is relatively simple, easy to commercially manufacture, and functionally reproducible.